{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:14:02Z","timestamp":1791645242924,"version":"4.3.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,4]]},"DOI":"10.7759\/cureus.44644","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T12:35:23Z","timestamp":1693830923000},"source":"Crossref","is-referenced-by-count":6,"title":["A Case Report of a Pregnant Woman With Type 2 Diabetes Mellitus Using Dulaglutide During the First Trimester of Pregnancy"],"prefix":"10.7759","author":[{"given":"Adel","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Alsaeddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashem","family":"Malki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameerah","family":"Alsaedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009494","article-title":"A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012","volume":"6","author":"Coton SJ","year":"2016","unstructured":"Coton SJ, Nazareth I, Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. BMJ Open. 2016, 6:e009494. 10.1136\/bmjopen-2015-009494","journal-title":"BMJ Open"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad AH","year":"2003","unstructured":"Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003, 289:76-9. 10.1001\/jama.289.1.76","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S008","article-title":"8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes-2023","volume":"46","author":"ElSayed NA","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al.. 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes-2023. Diabetes Care. 2023, 46:S128-39. 10.2337\/dc23-S008","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023","volume":"46","author":"ElSayed NA","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al.. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023. Diabetes Care. 2023, 46:S140-57. 10.2337\/dc23-S009","journal-title":"Diabetes Care"},{"key":"ref5","unstructured":"Eli Lilly and Company. Trulicity US [2020] prescribing information. (2020). https.\/\/pi.lilly.com\/us\/trulicity-uspi.pdf."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-022-01954-4","article-title":"A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus","volume":"60","author":"Burlina S","year":"2023","unstructured":"Burlina S, Dalfr\u00e0 MG, Caprino R, Lapolla A. A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus. Acta Diabetol. 2023, 60:137-8. 10.1007\/s00592-022-01954-4","journal-title":"Acta Diabetol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3573963","article-title":"The significance of exposure to pregestational type 2 diabetes in utero on fetal renal size and subcutaneous fat thickness","volume":"2022","author":"Pylypjuk CL","year":"2022","unstructured":"Pylypjuk CL, Day C, ElSalakawy Y, Reid GJ. The significance of exposure to pregestational type 2 diabetes in utero on fetal renal size and subcutaneous fat thickness. Int J Nephrol. 2022, 2022:3573963. 10.1155\/2022\/3573963","journal-title":"Int J Nephrol"},{"key":"ref8","article-title":"Fetal pyelectasis and Down syndrome: is genetic amniocentesis warranted?","volume":"79","author":"Corteville JE","year":"1992","unstructured":"Corteville JE, Dicke JM, Crane JP. Fetal pyelectasis and Down syndrome: is genetic amniocentesis warranted?. Obstet Gynecol. 1992, 79:770-2.","journal-title":"Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.11.009","article-title":"Pregnancy complicated by type 2 diabetes: an emerging problem","volume":"80","author":"Lapolla A","year":"2008","unstructured":"Lapolla A, Dalfr\u00e0 MG, Fedele D. Pregnancy complicated by type 2 diabetes: an emerging problem. Diabetes Res Clin Pract. 2008, 80:2-7. 10.1016\/j.diabres.2007.11.009","journal-title":"Diabetes Res Clin Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown E","year":"2021","unstructured":"Brown E, Heerspink HJ, Cuthbertson DJ, Wilding JP. SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. Lancet. 2021, 398:262-76. 10.1016\/S0140-6736(21)00536-5","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy HR","year":"2021","unstructured":"Murphy HR, Howgate C, O'Keefe J, et al.. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 2021, 9:153-64. 10.1016\/S2213-8587(20)30406-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2006.12.001","article-title":"A multicenter Italian study on pregnancy outcome in women with diabetes","volume":"18","author":"Lapolla A","year":"2008","unstructured":"Lapolla A, Dalfr\u00e0 MG, Di Cianni G, Bonomo M, Parretti E, Mello G. A multicenter Italian study on pregnancy outcome in women with diabetes. Nutr Metab Cardiovasc Dis. 2008, 18:291-7. 10.1016\/j.numecd.2006.12.001","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159132-a-case-report-of-a-pregnant-woman-with-type-2-diabetes-mellitus-using-dulaglutide-during-the-first-trimester-of-pregnancy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:46Z","timestamp":1707508666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159132-a-case-report-of-a-pregnant-woman-with-type-2-diabetes-mellitus-using-dulaglutide-during-the-first-trimester-of-pregnancy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.44644","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,4]]}}}